Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $4.2 million.

  • Xtant Medical Holdings' Free Cash Flow rose 20941.92% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 12993.06%. This contributed to the annual value of -$16.0 million for FY2024, which is 4592.11% down from last year.
  • As of Q3 2025, Xtant Medical Holdings' Free Cash Flow stood at $4.2 million, which was up 20941.92% from $910000.0 recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Free Cash Flow registered a high of $4.2 million during Q3 2025, and its lowest value of -$6.5 million during Q1 2024.
  • Its 5-year average for Free Cash Flow is -$1.6 million, with a median of -$1.5 million in 2022.
  • As far as peak fluctuations go, Xtant Medical Holdings' Free Cash Flow skyrocketed by 94752.48% in 2021, and later tumbled by 124532.02% in 2022.
  • Over the past 5 years, Xtant Medical Holdings' Free Cash Flow (Quarter) stood at -$203000.0 in 2021, then plummeted by 1245.32% to -$2.7 million in 2022, then soared by 53.2% to -$1.3 million in 2023, then surged by 99.45% to -$7000.0 in 2024, then soared by 59842.86% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q3 2025, $910000.0 for Q2 2025, and $87000.0 during Q1 2025.